Introduction
Infantile hemangiomas (IH) are
common, benign, vascular tumors of infancy which have a
characteristic clinical appearance and predictable natural history.
Classically, IH are not present at birth, but are noted shortly
thereafter. They proliferate for the first several months of life,
often rapidly, and then enter a stage of gradual involution. For
the vast majority of IH, no treatment is ever necessary, as
generally most involute completely over years without significant
scarring. However, for a minority of patients, hemangiomas can be
life- or function-threatening, or risk causing permanent
disfigurement, and these are the patients for whom treatment is
needed.
Which specific treatment and why
depends on the age of the patient, location, size, and anticipated
complications. Due to the heterogeneity of infantile hemangiomas,
the decision about when and how to intervene with treatment(s) are
made on an individual basis (1). Even in cases where high-risk or
concerning features are absent, but the rationale for treatment is
uncertain, active non-intervention is necessary (see
below) (2). The rationales for treatment are very diverse but can
be separated into three distinct categories, as listed below with
specific clinical scenarios for each of these areas:
1) To prevent
potentially life-threatening complications
a. Airway
hemangioma
b. Hepatic hemangioma
c. Giant hemangioma with or without internal involvement
2) To minimize
or prevent functional impairment or pain
a. Ulcerated
hemangioma
b. Periorificial hemangioma (periorbital, lip, anogenital)
c. Lumbosacral hemangioma
d. Segmental extremity hemangioma
3) To minimize
or prevent scarring and disfigurement
a.
Large/segmental facial hemangioma
b. Periocular/periauricular hemangioma
c. Central facial hemangioma developing prominent dermal
component
d. Nasal tip hemangioma
e. Pedunculated hemangioma
Discussion of potential treatments
for infantile hemangiomas requires in-depth knowledge of their
natural history and early recognition of possible associations and
complications.